Monte Rosa Therapeutics, Inc. GLUE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s total current assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported total current assets of $677.55M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s total current assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s total current assets increased by 103.9% year-over-year, from $332.28M to $677.55M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s total current assets has grown at a 55.3% compound annual growth rate (CAGR), from $43.59M to $393.19M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.